WEDNESDAY, Aug. 16, 2023 (HealthDay News) — All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation’s leading pediatrics group said. The American Academy of Pediatrics (AAP) urged that access to the new medication, called nirsevimab, be equitable. RSV is common, contagious andContinue Reading

TUESDAY, Aug. 15, 2023 (HealthDay News) — What researchers call ‘social factors’ are largely responsible for Black Americans having a greater risk of death from heart disease than whites, according to a new study. Among the social factors that contribute to this racial disparity are unemployment, low income, lack ofContinue Reading